Controlling postop pain, inflammation in cataract patients: drug delivery vs drops

Video
Conference|AAO

John A. Hovanesian, MD, discusses the highlights of his presentation on a clinical study evaluating dexamethasone vs prednisolone acetate 1% in controlling postop pain/inflammation in sequential cataract surgery patients.


John A. Hovanesian, MD, clinical instructor, UCLA Jules Stein Eye Institute, Laguna Hills, CA, discusses the highlights of his presentation titled "The D3 Study: Drug Delivery vs Drops — A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% in Controlling Post-operative Pain and Inflammation in Patients Undergoing Sequential Cataract Surgery," during the virtual 2020 American Academy of Ophthalmology (AAO) meeting.

See more AAO coverage here

Recent Videos
2 experts in this video
2 experts in this video
3 experts are featured in this series.
3 experts are featured in this series.
2 experts in this video
2 experts in this video
2 experts in this video
3 experts are featured in this series.
3 experts are featured in this series.
Related Content
An optometrist hands a paediatric patient her new glasses. Image credit: ©Yakobchuk Olena – stock.adobe.com

Hoya Vision Care expands MiYOSMART spectacle lens power range to offer broader range of negative and cylindrical powers

Emily Kaiser Maharjan
January 29th 2025
Article

The extension includes lenses that range from minus power of -13.00 diopters to cylindrical power up to 4.00 diopters

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

A petri dish with a fungal growth in solution sits beneath a microscope. Image credit: ©angellodeco – stock.adobe.com

Plant pathogen Macrophomina phaseolina may be emerging cause of ocular infection in humans

Lynda Charters
January 17th 2025
Article

A case report highlights the pathogen’s potential to cause severe, devastating ocular infections, despite aggressive treatment

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

Bausch + Lomb launches its enVista Aspire monofocal and toric intraocular lenses in the European Union

Bausch + Lomb launches its enVista Aspire monofocal and toric intraocular lenses in the European Union

Martin David Harp
January 13th 2025
Article

The launch follows a CE Mark received in late 2024

A microscope, petri dishes and a laptop sit in a laboratory, with researchers in the near distance. Image credit: ©pressmaster – stock.adobe.com

Conjunctival bacteria linked to higher fluoroquinolone resistance in new study from Brazil

Lynda Charters
January 8th 2025
Article

Clinicians need to better understand how to reduce the growth of antibiotic-resistant, more virulent bacteria, the authors said

© 2025 MJH Life Sciences

All rights reserved.